Craig D. Seaman

Emicizumab prophylaxis in patients with haemophilia A with and without inhibitors

Patrick T. Ebbert, Frederico Xavier, Craig D. Seaman et al. · Haemophilia · 2019 · 96 citations

Medicine, Hematology, Pharmacotherapy +16

<i>SMAC/Diablo</i> -dependent apoptosis induced by nonsteroidal antiinflammatory drugs (NSAIDs) in colon cancer cells

Manu Kohli, Jian Yu, Craig D. Seaman et al. · Proceedings of the National Academy of Sciences · 2004 · 69 citations · Full text

Medicine, Oncology, Pharmacology +17

Venous thromboembolism in pregnant women with sickle cell disease: A retrospective database analysis

Craig D. Seaman, Jonathan G. Yabes, Jie Li et al. · Thrombosis Research · 2014 · 53 citations

Medicine, Hematology, Obstetrics +17

Does deficiency of von Willebrand factor protect against cardiovascular disease? Analysis of a national discharge register

Craig D. Seaman, Jonathan G. Yabes, Diane Comer et al. · Journal of Thrombosis and Haemostasis · 2015 · 48 citations · Full text

Medicine, Cardiology, Internal Medicine +16

Cost-effectiveness of rivaroxaban versus warfarin anticoagulation for the prevention of recurrent venous thromboembolism: A U.S. perspective

Craig D. Seaman, Kenneth J. Smith, Margaret V. Ragni · Thrombosis Research · 2013 · 42 citations

Medicine, Pharmacoeconomics, Pharmacotherapy +13